Type 2 Diabetes
What is Type 2 Diabetes?
Type 2 diabetes is a chronic metabolic disorder characterized by high blood sugar levels resulting from insulin resistance and relative insulin deficiency. Unlike type 1 diabetes, the pancreas still produces insulin, but the body’s cells become resistant to its effects, leading to inadequate glucose control. This condition affects people of all ages but is most commonly diagnosed in adults over 45. Type 2 diabetes accounts for approximately 90-95% of all diabetes cases worldwide and has reached epidemic proportions globally, affecting over 400 million people.
Key statistics
| Statistic | Value |
|---|---|
| Global prevalence | 463 million adults (2019) |
| Annual deaths | 4.2 million diabetes-related deaths |
| Peak age of onset | 45-65 years |
| Projected 2045 cases | 700 million adults |
Symptoms
Common early symptoms: Increased thirst, frequent urination, increased hunger, unexplained weight loss, fatigue, blurred vision, slow-healing wounds.
Type 2 diabetes often develops gradually, and many people experience no symptoms initially. Increased thirst and frequent urination occur as the kidneys work to eliminate excess glucose through urine. Unexplained fatigue results from cells being unable to effectively use glucose for energy. Blurred vision happens when high blood sugar levels cause the lens of the eye to swell. Slow-healing cuts and wounds reflect impaired immune function and circulation. Tingling or numbness in hands and feet may indicate early nerve damage. Recurring infections, particularly skin, gum, or urinary tract infections, become more common due to elevated glucose levels creating favorable conditions for bacteria.
Causes and risk factors
Type 2 diabetes results from a combination of genetic predisposition and environmental factors. The primary mechanism involves insulin resistance, where cells become less responsive to insulin, followed by progressive decline in pancreatic beta cell function.
Genetic factors play a significant role, with family history increasing risk substantially. Multiple genes contribute to susceptibility, including variants affecting insulin action and pancreatic function.
Major risk factors include: Obesity (especially abdominal fat), sedentary lifestyle, age over 45, family history of diabetes, gestational diabetes history, polycystic ovary syndrome, high blood pressure, abnormal cholesterol levels, and certain ethnicities (African American, Hispanic, Native American, Asian American, Pacific Islander). Environmental triggers include poor diet high in processed foods and refined sugars, chronic stress, inadequate sleep, and certain medications such as corticosteroids.
Prevention
Type 2 diabetes is largely preventable through lifestyle modifications. The Diabetes Prevention Program demonstrated that lifestyle changes can reduce diabetes risk by 58% in high-risk individuals.
Evidence-based prevention strategies include: Maintaining healthy weight (losing 5-10% of body weight if overweight), engaging in regular physical activity (150 minutes of moderate exercise weekly), following a balanced diet rich in whole grains, vegetables, and lean proteins while limiting processed foods and sugary beverages, and avoiding tobacco use.
Screening recommendations: Adults over 45 should be screened every three years, or earlier if risk factors are present. High-risk individuals should be tested annually using fasting plasma glucose, hemoglobin A1C, or oral glucose tolerance test. Pre-diabetes identification allows for intensive lifestyle intervention to prevent progression to diabetes.
Complications
Untreated or poorly controlled type 2 diabetes can lead to serious complications affecting multiple organ systems. Cardiovascular disease is the leading cause of death, with diabetes increasing heart attack and stroke risk by 2-4 times. Diabetic nephropathy can progress to kidney failure requiring dialysis or transplantation. Diabetic retinopathy may cause vision loss and blindness. Diabetic neuropathy affects nerves throughout the body, causing pain, numbness, and potentially leading to foot ulcers and amputations.
Additional complications include: Increased infection susceptibility, delayed wound healing, dental disease, hearing impairment, sleep apnea, depression, and dementia. Acute complications such as diabetic ketoacidosis (less common in type 2) and hyperosmolar hyperglycemic syndrome can be life-threatening.
Diagnosis
Type 2 diabetes diagnosis relies on blood glucose measurements using standardized criteria. Diagnostic tests include: Fasting plasma glucose (≥126 mg/dL), hemoglobin A1C (≥6.5%), oral glucose tolerance test (≥200 mg/dL at 2 hours), or random plasma glucose (≥200 mg/dL with symptoms).
Additional assessments include lipid profile, kidney function tests (serum creatinine, urine albumin), liver function tests, thyroid function, and vitamin B12 levels. C-peptide and autoantibody testing may help differentiate from type 1 diabetes in unclear cases. Regular monitoring includes quarterly A1C testing, annual eye exams, foot examinations, and cardiovascular risk assessment.
Treatment
Type 2 diabetes management involves lifestyle modifications and often requires medications to achieve target blood glucose levels (A1C First-line treatment typically includes metformin combined with lifestyle changes. Additional medications may include sulfonylureas like glipizide, DPP-4 inhibitors such as sitagliptin, GLP-1 receptor agonists like liraglutide, SGLT-2 inhibitors such as empagliflozin, and insulin when needed.
Comprehensive care includes: Blood pressure management with ACE inhibitors or ARBs, cholesterol control with statins, aspirin therapy for cardiovascular protection when appropriate, and regular monitoring of blood glucose, kidney function, and eye health.
Prognosis
With proper management, people with type 2 diabetes can live normal lifespans with good quality of life. Early diagnosis and aggressive treatment significantly improve outcomes. Well-controlled diabetes (A1C consistently below 7%) dramatically reduces complication risks.
Long-term outlook depends on: Age at diagnosis, degree of blood sugar control, presence of complications at diagnosis, adherence to treatment, and cardiovascular risk factors. Studies show that intensive glucose control can reduce microvascular complications by 25% and cardiovascular events by 17%. However, diabetes remains a leading cause of blindness, kidney failure, and lower-limb amputations when poorly managed.
Quality of life
Living well with type 2 diabetes requires ongoing self-management and lifestyle adjustments. Daily blood glucose monitoring helps track control and guide treatment decisions. Dietary management involves carbohydrate counting, portion control, and consistent meal timing while focusing on nutrient-dense foods with low glycemic impact.
Regular exercise improves insulin sensitivity and glucose control. Both aerobic activity and resistance training provide benefits. Stress management through relaxation techniques, adequate sleep (7-9 hours nightly), and social support networks significantly impact glucose control.
Workplace accommodations may include flexible schedules for medical appointments, access to snacks for hypoglycemia prevention, and private areas for blood glucose testing and medication administration. Mental health support addresses diabetes distress, depression, and anxiety that commonly accompany chronic disease management.
Pregnancy and fertility
Type 2 diabetes can affect fertility in both men and women, though pregnancy is generally possible with proper management. Pre-conception planning is crucial, including optimizing blood glucose control (A1C Pregnancy considerations include increased insulin requirements, more frequent monitoring, dietary modifications, and potential medication changes. Some diabetes medications are contraindicated during pregnancy, requiring transition to insulin. Gestational complications may include macrosomia, preeclampsia, preterm delivery, and neonatal hypoglycemia. Close collaboration between endocrinologists and obstetricians ensures optimal outcomes for mother and baby.
Children
Type 2 diabetes in children and adolescents has increased dramatically, often associated with childhood obesity and sedentary lifestyles. Pediatric presentation may include symptoms similar to adults but can progress more rapidly than in adults.
Management challenges include adherence difficulties during adolescence, family involvement in lifestyle changes, school accommodation for blood glucose monitoring and medication administration, and addressing psychosocial impacts. Treatment approaches emphasize lifestyle modification as first-line therapy, with metformin and insulin as primary medication options approved for pediatric use. Transition to adult care requires careful planning to maintain continuity and prevent gaps in management.
When to see a doctor
Seek immediate medical attention for: Blood glucose above 400 mg/dL, signs of dehydration, persistent vomiting, difficulty breathing, confusion, severe abdominal pain, or signs of serious infection.
Schedule routine appointments for: Persistent symptoms of high blood sugar, family history of diabetes with concerning symptoms, or results from screening tests suggesting pre-diabetes or diabetes. Regular follow-up visits should occur every 3-6 months for diabetes management, medication adjustments, and complication screening.
Regional context
Limited specific data exists for type 2 diabetes prevalence in the Caucasus region, though regional dietary patterns and genetic factors may influence disease characteristics. Traditional Caucasian diets high in whole grains and vegetables may offer protective benefits, while increasing urbanization and Western dietary adoption may increase risk. GMJ welcomes contributions from regional researchers to build the evidence base for type 2 diabetes in the Caucasus.
Research and clinical trials
Current research focuses on novel therapeutic targets including dual GLP-1/GIP receptor agonists, improved insulin formulations, and beta cell preservation strategies. Emerging areas include continuous glucose monitoring integration, artificial pancreas systems, and personalized medicine approaches based on genetic profiles.
Recent breakthroughs include SGLT-2 inhibitors showing cardiovascular and renal benefits beyond glucose control, and GLP-1 receptor agonists demonstrating weight loss and cardiovascular protection. Clinical trials information is available through ClinicalTrials.gov for patients interested in participating in research studies.
Frequently asked questions
Can type 2 diabetes be reversed?
Type 2 diabetes can potentially be put into remission through significant weight loss, intensive lifestyle changes, or bariatric surgery, but this requires ongoing maintenance and monitoring.
How often should I check my blood sugar?
Frequency depends on treatment type and control level. Those on insulin may need multiple daily checks, while those on oral medications might test 1-2 times daily or several times weekly.
Will I definitely need insulin eventually?
Not necessarily. Many people manage type 2 diabetes long-term with oral medications and lifestyle changes, though insulin may become necessary as pancreatic function declines over time.
Can I eat sugar if I have diabetes?
Small amounts of sugar can be incorporated into a balanced meal plan, but focus should be on complex carbohydrates, portion control, and overall dietary quality rather than complete sugar elimination.
Is type 2 diabetes genetic?
Genetics play a significant role, but environmental factors are equally important. Having family history increases risk but doesn’t guarantee developing diabetes.
Support and resources
International organizations: International Diabetes Federation (https://www.idf.org), American Diabetes Association (https://www.diabetes.org), Diabetes UK (https://www.diabetes.org.uk), and World Health Organization Diabetes Programme (https://www.who.int/diabetes).
Additional resources: Academy of Nutrition and Dietetics for dietary guidance, Juvenile Diabetes Research Foundation for research information, and local diabetes education programs through healthcare systems and community centers.
Related conditions
Type 1 diabetes – Autoimmune destruction of pancreatic beta cells requiring insulin therapy. Gestational diabetes – Glucose intolerance first diagnosed during pregnancy. Metabolic syndrome – Cluster of conditions increasing diabetes and heart disease risk. Prediabetes – Elevated blood glucose levels below diabetes threshold. Diabetic ketoacidosis – Serious complication involving dangerous blood acid levels.
Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, UpToDate, relevant EULAR/ACR/WHO guidelines. This article is for informational purposes only and does not constitute medical advice. Content licensed under CC BY 4.0.
Cite this page
GMJ News Desk. “Type 2 Diabetes.” GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/condition/type-2-diabetes/
Licensed under CC BY 4.0. Free to share with attribution to GMJ News.Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, EULAR/ACR guidelines. Schema.org MedicalCondition structured data included.
Was this article helpful?
- Preoperative Exercise Improves Recovery in Elderly Spinal Fusion Patients, New Trial Shows · Jul 13, 2026
- Eight Common Food Additives Linked to Hypertension and Cardiovascular Disease in Large Cohort Study · Jul 13, 2026
- GLP-1 Drugs Linked to Lower Violent Behaviour in Rutgers Study · Jul 11, 2026
- Oral GLP-1 medication shows major promise for type 2 diabetes: weight loss and blood sugar control in pivotal trial · Jul 11, 2026
- Return migrants in sub-Saharan Africa face persistent health barriers despite homecoming, scoping review finds · Jul 11, 2026


